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Abstract
Aberrant DNA methylation patterns have been linked to molecular and cellular alterations in the aging brain. Caloric restriction (CR) and
upregulation of antioxidants have been proposed as interventions to prevent or delay age-related brain pathology. Previously, we have shown
in large cohorts of aging mice, that age-related increases in DNA methyltransferase 3a (Dnmt3a) immunoreactivity in the mouse
hippocampus were attenuated by CR, but not by overexpression of superoxide dismutase 1 (SOD1). Here, we investigated age-related
alterations of 5-methylcytidine (5-mC), a marker of DNA methylation levels, in a hippocampal subregion-specific manner. Examination of
5-mC immunoreactivity in 12- and 24-month-old wild type (WT) mice on control diet, mice overexpressing SOD1 on control diet, wild type
mice on CR, and SOD1 mice on CR, indicated an age-related increase in 5-mC immunoreactivity in the hippocampal dentate gyrus, CA3,
and CA1–2 regions, which was prevented by CR but not by SOD1 overexpression. Moreover, positive correlations between 5-mC and
Dnmt3a immunoreactivity were observed in the CA3 and CA1–2. These findings suggest a crucial role for DNA methylation in hippocampal
aging and in the mediation of the beneficial effects of CR on aging.
© 2012 Elsevier Inc.
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Aging of the brain is associated with various molecular
and morphological alterations that can lead to cognitive
decline and increased risk for the development of neurode-
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Open access under the Elsevier OA license.generative diseases. Brain shrinkage, neuronal loss, in-
creased DNA damage, vascular dysfunction, and changes in
numbers and morphology of dendritic spines have all been
linked with the selective vulnerability to aging of hippocam-
pal and neocortical circuits (Dickstein et al., 2007, 2010;
Luebke et al., 2010; Rutten et al., 2003, 2007). Recently, the
epigenetic mechanism of DNA methylation, has been linked
to mediation of the age-related alterations in gene expres-
sion and with memory formation (Calvanese et al., 2009;
Chouliaras et al., 2010a; Day and Sweatt, 2010; Fraga and
Esteller, 2007; Levenson et al., 2006; Liu et al., 2009; Miller
and Sweatt, 2007; Murgatroyd et al., 2010; Penner et al.,
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ferases (Dnmts) in mice have been shown to affect memory
processing (Feng et al., 2010; Levenson et al., 2006). We
recently reported an age-related increase in Dnmt3a levels
in the mouse hippocampus, which was prevented by caloric
restriction (CR) (Chouliaras et al., 2011). CR has been
previously shown to increase lifespan, prevent age-related
alterations, and delay disease onset in many species (Adams
et al., 2008; Anderson et al., 2009; Bordone and Guarente,
2005; Colman et al., 2009; Levenson and Rich, 2007; Mas-
wood et al., 2004; Mattson et al., 2002; Mouton et al., 2009;
Patel et al., 2005; Sohal and Weindruch, 1996), possibly
acting via altering epigenetic mechanisms. Besides CR,
upregulation of the endogenous human antioxidant Cu/Zn-
superoxide dismutase 1 (SOD1) has been shown to reduce
oxidative damage to DNA and prevent neurodegeneration
after brain injury in rodents (Borg and London, 2002; Cadet
et al., 1994; Cardozo-Pelaez et al., 1998; Chan et al., 1994;
Rutten et al., 2002), while oxidative stress has also been
described to impact on DNA methylation.
Cohorts of wild type and transgenic mice overexpressing
SOD1 were generated, fed with either a control diet or a diet
restricted in calories, which were examined at 12 and 24
months of age. Recently, we reported reductions in hip-
pocampal volumes associated with aging and CR (Rutten et
al., 2010), as well as increased hippocampal Dnmt3a im-
munoreactivity (IR) with aging that was prevented by ca-
loric restriction (Chouliaras et al., 2011). In the present
study, levels of DNA methylation in situ, by immunohisto-
chemical analysis of 5-mC, were examined in a hippocam-
pal subregion-specific analysis aiming to investigate the
effects of aging, CR, and overexpression of SOD1 on DNA
methylation levels and test whether levels of 5-mC correlate
with Dnmt3a levels.
2. Methods
2.1. Animals
Wild type (WT) C57Bl6J and transgenic mice overexpress-
ing normal human SOD1 were used, derived from a total
cohort of 240 male mice. Both types of animals were assigned
to receive either a control diet (CD) or a calorie restricted diet.
Details on the generation and characterization of the cohort,
preparation of the diets, and weight and survival curves of the
animals have been described previously (Rutten et al., 2010;
Weindruch et al., 1986). Briefly, the cohort was generated from
4 breeder pairs of female WT C57Bl6J and male transgenic
hemizygous for SOD1 on a C57Bl6J background (carrying 7
copies of the entire human SOD1 sequence, in order to achieve
increased expression and enzyme activity in brain and other
tissues; Epstein et al., 1987; Przedborski et al., 1992). The
animals were assigned to the 2 diet groups after weaning and
for their entire life. The reduction of caloric intake in the CR
groups was approximately 50%, while the CD was approxi-
mately 85% of the ad libitum consumption, in order to monitorthe caloric intake and ensure that all the food pellets would be
consumed. The detailed compositions, feeding patterns, and
the weight and survival curves have been reported by (Rutten
et al., 2010). All experiments were carried on the Central
Animal Facilities, Maastricht University, Maastricht, The
Netherlands, and the animals were maintained under standard
temperature and humidity conditions on a 12-hour light-dark
circle, housed individually, with water available ad libitum,
under specified pathogen-free conditions. All experiments
were approved by the Animals Ethics Board of Maastricht
University.
2.2. Experimental design
Four groups were generated, based on the genotype and diet
of the animals: (1) WT mice on control diet (WT-CD), (2)
SOD1 mice on control diet (SOD1-CD), (3) WT mice on
caloric restriction (WT-CR), and (4) SOD1 mice on caloric
restriction (SOD1-CR). Six animals from each group were
euthanized at the age of 12 months and another 6 animals per
group at 24 months of age for histological analyses.
2.3. Tissue processing
The animals were deeply anesthetized and transcardially
perfused with 20 mL tyrode solution and 20 mL of fixative
solution (4% parafolmaldehyde, 0.9% NaCl) followed by 30
mL of a second fixative solution (8% parafolmaldehyde, 0.9%
NaCl, 1% acetic acid). After removal, the brains were post-
fixed at 4 °C for 24 hours in the 8% parafolmaldehyde, without
the acetic acid. Consequently, the brains were hemisected in
the midsagittal line, cryoprotected in sucrose solution (10%,
20%, and finally 30% sucrose in Tris-HCl buffer, 2 12 hours
per solution at 4 °C) and embedded in Tissue Tek® (Sakura
inetec Europe, Zoeterwoude, The Netherlands). Then, the left
rain halves were quickly frozen and stored at 80 °C, until
hey were cut serially in 30-m thick free-floating coronal
ections using a cryostat (type HM 500 OMV, Microm, Wall-
orf, Germany), yielding 10 subseries of every tenth section,
nd stored until further histological processing. The right brain
alves were not used in the present study.
.4. Immunohistochemical detection of 5-mC
Using standard immunohistochemical procedures that were
reviously described (Chouliaras et al., 2011), with a mouse
onoclonal anti-5-mC (dilution 1:500; GenWay Biotech, San
iego, CA, USA) as primary antibody and a donkey anti-
ouse biotine (dilution 1:200; Jackson, Westgrove, PA, USA)
s a secondary antibody, a series of sections containing the
ippocampus were stained. In order to visualize the reaction
roduct, the sections were incubated in 3,3=-diaminobenzidine
etrahydrochloride (DAB) solution (1:1 3,3=-diaminobenzidine
etrahydrochloride: Tris-HCl, 0.3% H2O2) (Sigma, Uithoorn, The
Netherlands) for 10 minutes. Control experiments, omitting
the primary antibody or using an anti-5-mC primary antibody
from another company (Santa Cruz, CA, USA) confirmed the
specificity of immunoreactivity (data not shown).
P
a
w
c
(
p
p
(
T
g
d
g
s
p
p
e
p
p
m
r
t
t
p
o
a
g
I
2
a
o
1674 L. Chouliaras et al. / Neurobiology of Aging 33 (2012) 1672–16812.5. Immunofluorescent labeling of 5-mC and DAPI
After incubation with the primary and secondary antibodies
(see above), the sections were incubated with streptavidin
Alexa Fluor 594 conjugate (Invitrogen, Eugene, OR, USA)
and counterstained with 4=,6-diamidino-2-phenylindole dihy-
drochloride (DAPI; Sigma Aldrich, Zwijndrecht, The Nether-
lands).
2.6. Analysis of 5-mC IR
2.6.1. Mean intensity and surface area of 5-mC IR
Gray value measurements and percentage of surface area
below (i.e., darker as compared with) the calculated threshold
(see below) were used for the assessment of 5-mC IR. As
illustrated using the white boxes in Fig. 1A, 4 images from the
granule cell layer of the dentate gyrus (DG), 2 images from the
CA3 cell layer, and 2 images from the CA1–2 regions were
taken in 4 selected sections per series, at 4 bregma levels
(1.58, 1.82, 3.40, and 3.52) according to Franklin and
axinos (1997). Thus, a total of 32 images per animal were
nalyzed. The images were taken using the 40 objective,
ith a digital camera (f-view; Olympus, Tokyo, Japan)
onnected to an Olympus AX70 brightfield microscope
analySIS; Imaging System, Münster, Germany). The
attern of the staining revealed densely stained small
articles, reflecting hypermethylated DNA fragments
Brown et al., 2008; Hernandez-Blazquez et al., 2000).
hreshold values were set in order to correct for back-
round signal (Strackx et al., 2008). Surface area was
efined as the percentage of the area delineated with a
ray value below the background threshold. Further, the
urface area measurements were corrected for total hip-
ocampal volume differences (Rutten et al., 2010), sim-
Fig. 1. 5-Methylcytidine (5-mC) immunoreactivity (IR) in mouse hippoca
level1.58). The white boxes indicate the places where the high-magnifica
(DG), 2 images per sections for CA3, and 2 images per section for CA1–2). Scaly by multiplying the surface area by the volume. How-
ver, the surface area measurements, despite the
erformed corrections, might still be hampered by hip-
ocampal volume differences. Therefore, in addition,
ean gray values were calculated in order to further
eplicate the results. The mean gray value was defined as
he sum of gray values of all pixels below the calculated
hreshold in the selected area divided by the number of all
ixels, and such measurement is independent of volume
r even cell number differences. Results on gray values
re represented as mean intensity, i.e., the inverse mean
ray value, with higher intensities representing increased
R.
.6.2. Imaging of 5-mC and DAPI
Colocalization of 5-mC and DAPI was demonstrated
fter double immunofluorescence (Fig. 2A–F). Image stacks
f 16-m thick and consisting of 80 confocal images (0.2
m apart) of double-labeled cell particles were made with a
100 objective (Olympus UPlanSApo; numerical aperture
[NA]  1.40) and the SI-SD system (MBF Bioscience,
Williston, VT, USA). The system consisted of a modified
Olympus BX51 fluorescence microscope with customized
spinning disk unit (DSU; Olympus), computer-controlled
excitation and emission filterwheels (Olympus), 3-axis
high-accuracy computer-controlled stepping motor speci-
men stage (4  4 Grid Encoded Stage, Ludl Electronic
Products, Hawthorne, NY, USA), linear z-axis position en-
coder (Ludl), ultra-high sensitivity monochrome electron
multiplier CCD camera (1000  1000 pixels, C9100-02,
Hamamatsu Photonics, Hamamatsu City, Japan) and con-
trolling software (StereoInvestigator; MBF BioScience,
Williston, VT, USA).
epresentative image of a hippocampal section stained for 5-mC (bregma
ges were taken for the analysis (i.e., 4 images per section for dentate gyrusmpus. R
tion imale bar  165 m (see text for more details).
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Dnmt3a IR was assessed previously in sections from the
same mouse brains that were used in the present study.
Pearson’s correlation coefficient (rp) was calculated for gray
alues when correlating Dnmt3a IR with 5-mC IR per
ippocampal subregion per animal.
.8. Statistical analysis
All data are presented as mean and standard error of
he mean. The general linear model univariate analysis of
ariance was used for comparisons between groups, ac-
ounting for the main and interactive effects of age,
enotype, and diet. Statistical significance was set at an 
level of 0.05. Pair-wise comparisons were performed
with a Bonferroni post hoc test. All statistical calcula-
tions were performed using the Statistical Package for the
Social Sciences, (SPSS 16, SPSS, Inc., Chicago, IL,
USA). Graphs were built in GraphPad Prism (Version 4,
GraphPad Software, San Diego, CA, USA).
3. Results
3.1. Qualitative analysis of 5-mC IR
Nuclear IR of 5-mC was observed in cells throughout the
hippocampus (see Fig. 3). Qualitative microscopic inspec-
ion of the stained section indicated an evident and profound
Fig. 2. 5-Methylcytidine (5-mC) and 4=,6-diamidino-2-phenylindole dih
hippocampal cell in a 12-month-old mouse showing fluorescent labeling of
location and focal plane, with merged pictures in (C) and (F), showing col
text for more details). Images (D–F) show 3-dimensional reconstructions. S
ade with the Imaris software program (Bitplane AG, Zurich, Switzerlanncrease in 5-mC IR occurring with aging, which seemed tobe attenuated in animals fed with CR (Fig. 3). Quantitative
analyses were carried out to confirm these findings. Further,
colocalization with DAPI showed qualitative verification of
the nuclear signal (see Fig. 2). The densely-stained 5-mC-
immunoreactive particles colocalized with the DAPI signal
(Fig. 2C).
3.2. 5-mC intensity
Mean intensity of 5-mC IR (Fig. 4A–C) was increased with
aging from 12- to 24-month-old mice in all investigated re-
gions (p  0.028 for DG; p  0,004 for CA3 and p  0.009
or CA1–2) and decreased by CR diet only in the CA3 (p 
0.005) and CA1–2 (p  0.002) regions. Interestingly, age 
diet interactions were also observed for all hippocampal sub-
regions investigated (p  0.037 for DG; p  0.001 for CA3;
and p  0.002 for CA1–2). Pairwise post hoc comparisons
sing Bonferroni correction in the CA3 region showed a sig-
ificant increase of 5-mC IR in 24-month-old WT-CD mice as
ompared with 12-month-old WT-CD mice ( 9.3%, p 
0.024) and similarly for SOD1-CD mice (24- vs. 12-month-
old, 11.2%; p 0.005). On the contrary, a decrease of 5-mC
R was observed when comparing 24-month-old WT-CR to
4-month-old WT-CD mice (10.6%, p  0.005) and 24-
month-old SOD1-CR to 24-month-old SOD1-CD mice
(9.6%, p  0.034). In the CA1–2 region post hoc compar-
isons showed a decrease in 5-mC IR in 24-month-old WT-CR
mice when compared with 24-month-old WT-CD mice
loride (DAPI) colocalization. Representative images of a nucleus of a
(blue) in (A) and (D), and 5-mC (red) in (B) and (E), at the corresponding
ion (pink). All images represent 1 stack taken with the SI-SD system (see
r 3 m. Projections and minor corrections in intensity and contrast wereydroch
DAPI
ocalizat
cale ba(10.6%, p  0.029). No specific effects of the SOD1 geno-
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of 5-mC IR in the CD groups but not in the CR groups.
3.3. 5-mC surface area
In the same way (Fig. 4D–F), diet (CR vs. CD) decreased
the surface area of 5-mC IR in the DG (p  0.038) and age
24 months vs. 12 months) increased it in the CA1–2 region
p  0.041). Furthermore, significant age  diet interac-
ions were observed in all hippocampal subregions (p 
.007 for DG; p  0.01 for CA3, and p  0.01 for CA1–2),
pointing to an age-related increase in the CD groups that
was not observed in the CR groups. No effects of the SOD1
genotype were observed. Furthermore, pair-wise post hoc
comparisons with Bonferroni correction showed no signif-
icant differences among individual groups.
3.4. 5-mC and Dnmt3a correlation analysis
Previously, we observed, in the same cohort of mice,
age-related changes of Dnmt3a IR that were attenuated by
CR (Chouliaras et al., 2011). Thus, correlation analysis
Fig. 3. Representative images of 5-methylcytidine (5-mC) immunoreactiv
hippocampal regions dentate gyrus (DG), CA3, and CA1–2 are presented fo
CD mouse in (D), (E), and (F), for a 12-month-old caloric restriction (CR
(L). Note: An evident increase in 5-mC IR from 12 to 24 months in CD m
bjective while the images in the bottom right box of each micrograph w
high-magnification images in the bottom right boxes.between 5-mC and Dnmt3a gray values was carried out, inorder to examine to what extent the observed changes in
5-mC IR may be mediated, at least in part, by Dnmt3a.
Positive linear correlation was observed in the CA3 (rp 
.490, p  0.001) and CA1–2 (rp  0.408, p  0.007)
regions, but not in the DG (Fig. 5A–C).
4. Discussion
Qualitative and quantitative assessment of 5-mC IR re-
vealed densely-stained hypermethylated regions with nu-
clear localization, which were more pronounced in brains of
24-month-old animals when compared with 12-month-old
mice. The age-related increase in 5-mC IR observed in CD
animals was not observed in CR animals, suggesting that
CR prevented these age-related alterations. In contrast, mice
overexpressing SOD1 did not show any differences as com-
pared with WT mice. Positive correlation with previously
reported Dnmt3a IR analysis showed that the changes in
5-mC IR in CA3 and CA1–2 are associated with alterations
). High-magnification images of 5-mC IR. Representative images of the
onth-old control diet (CD) mouse in (A), (B), and (C), for a 24-month-old
e in (G), (H), and (I), and for a 24-month-old CR mouse in (J), (K), and
hich is not seen in CR mice. The full size images were taken with a 40
00 objective. Scale bar  20 m in images (A–L) and 50 m in theity (IR
r a 12-m
) mous
ice, w
ith a 1in Dnmt3a.
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DNA methylation is a dynamic process subject to envi-
ronmental influences and the aging process (Day and Swe-
att, 2010; McGowan et al., 2009; Meaney and Ferguson-
Smith, 2010; Murgatroyd et al., 2009; Rutten and Mill,
2009; Zhang et al., 2010). For instance, it has been shown
that DNA methylation differences between monozygotic
twins increase with age (Fraga et al., 2005). Furthermore,
aberrant methylation patterns have been described in aging,
such as global hypomethylation as well as hypermethylation
Fig. 4. 5-Methylcytidine (5-mC) intensity and surface area. Mean and
immunoreactivity (IR) (A–F). Pooled data from the 4 groups of 12-month-
dentate gyrus (DG) (A and D), CA3 (B and E), and CA1–2 (C and F). Su
differences. The significant effects observed of each analysis are noted
ignificant.
Fig. 5. 5-Methylcytidine (5-mC) and DNA methyltransferase 3a (Dnmt3a
Dnmt3a IR for the dentate gyrus (DG), CA3 and CA1-2. Significant Spearman’sof CpG islands, i.e. genomic regions rich in nucleotide
sequences of cytosine (C) followed by guanine (G) (Chris-
tensen et al., 2009; Murgatroyd et al., 2010; Siegmund et al.,
2007), whereas in the rodent hippocampus, age-associated
DNA methylation changes of the memory-related Arc gene
have been reported (Penner et al., 2010b). In addition,
a global loss of 5-mC and methylation stabilizing fact-
ors, such as Dnmt1 and methyl-CpG binding protein 2
(MeCP2), has been observed in brains of Alzheimer’s dis-
ease (AD) patients when compared with aged-matched con-
rd error of the mean of mean intensity value measurements of 5-mC
ite bars) and 24-month-old mice (black bars) are presented separately for
ea occupied by 5-mC IR measurements (D–F) were corrected for volume
op right corner of each graph. p  0.05 was considered as statistically
lation analysis. Correlation analysis of 5-mC immunoreactivity (IR) andstanda
old (wh
rface ar
in the t) corre
correlation coefficients are noted in the bottom right of each graph.
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served in a case report of a monozygotic twin pair
discordant for AD (Mastroeni et al., 2009). Various other
studies have shown epigenetic dysregulation in AD, point-
ing toward a shift from normal aging to AD, possibly related
to stochastic factors, sustainable effects of environmental
exposures, as well as gene  environment interactions
(Avramopoulos et al., 2011; Cao et al., 2010; Chouliaras et
al., 2010a, 2010b; Fuso and Scarpa, 2011; Lahiri et al.,
2009; Mastroeni et al., 2011; Wang et al., 2008). As the
5-mC IR mainly reflects DNA methylation in CpG-rich
regions, our findings are compatible with the previously
reported age-associated hypermethylation of CpG islands,
within the brain and other tissues (Christensen et al., 2009;
Fraga and Esteller, 2007; Fraga et al., 2007; Siegmund et al.,
2007). Furthermore, increased CpG methylation with aging
has been reported in the frontal cortex, temporal cortex,
pons, and cerebellum of human brains, with the hyperm-
ethylated loci mainly situated in genes related to DNA
binding and transcriptional regulation (Hernandez et al.,
2011). Moreover, the functional impact of the observed
increased hippocampal levels of 5-mC with aging is thus not
yet clear, but may contribute to age-related changes in gene
expression and their regional specificity (Berchtold et al.,
2008; Haberman et al., 2009; Penner et al., 2010b).
4.2. Correlation of Dnmt3a and 5-mC
Previously, we reported an age-related increase of
Dnmt3a IR that was also attenuated by CR (Chouliaras et
al., 2011). Dnmt3a is a de novo methyltransferase, impli-
cated in learning, memory, and associated synaptic plastic-
ity and neurogenesis. The observed positive correlation be-
tween Dnmt3a and 5-mC IR suggests that Dnmt3a could be
a mediator of increased 5-mC IR in the CA1–2 and CA3
regions.
4.3. Prevention of age-related increase in 5-mC by
caloric restriction
The age-related increase in 5-mC IR observed in the
mouse hippocampus was prevented by CR. While an in-
crease in 5-mC IR was found in 24-month-old CD mice as
compared with the 12-month-old animals, CR mice did not
show such age-related differences. The mechanism of this
effect is not yet fully clear. So far, it is known that dietary
and nutritional factors can alter DNA methylation patterns
by affecting the 1 carbon metabolism, the main regulator of
the methylation potential (Sugden, 2006). For instance, it
has been shown that dietary manipulations targeting the 1
carbon metabolism may impact on methylation of various
genes that have been linked to neurodegeneration (Fuso et
al., 2011; Scarpa et al., 2006). Furthermore, a wealth of
evidence suggests that the beneficial effects of CR are
mediated by sirtuins, molecules with histone deacetylase
properties (Blander and Guarente, 2004; Bordone and Guar-
ente, 2005; Chen and Guarente, 2007; Chen et al., 2005, v2008; Dillin and Kelly, 2007) and that regulation of chro-
matin via histone alterations is intrinsically intertwined with
the regulation of DNA methylation (Dong et al., 2007;
Kishikawa et al., 2002). Thus, it is reasonable to speculate
that CR induces both changes in DNA methylation as well
as chromatin modifications and that these epigenetic
changes are causally involved in the beneficial effects on
life span.
4.4. No effects of SOD1 overexpression
Mice overexpressing SOD1 did not show any differences
as compared with WT mice. Such a finding is in line with
our previous reports of no effects of SOD1 on brain vol-
umes (Rutten et al., 2010) and Dnmt3a (Chouliaras et al.,
2011). Although the role of oxidative damage in aging has
been well documented, its possible reduction by SOD1 did
not show any effect in relation to 5-mC IR or previously
reported Dnmt3a IR. Either 5-mC IR is not directly related
to changes in oxidative stress, or such changes are not
reflected in the hippocampus, or the levels of SOD1 and
other antioxidants in this model were not sufficient enough
to attenuate the effects of aging (Epstein et al., 1987; Pr-
zedborski et al., 1992).
4.5. Strengths and limitations
Besides the major strengths and limitations of the study
design, as discussed previously (Chouliaras et al., 2011;
Rutten et al., 2010), one of the major strengths of the present
study is that the standard and controlled conditions under
which the animals were kept minimize the effects of vari-
ations in the environment and point to effects of stochastic
factors during life. Furthermore, in contrast to DNA ex-
tracted from tissue homogenates, the in situ DNA methyl-
ation detection by using a specific 5-mC antibody does not
affect the integrity of the region of interest, allowing the
identification of neuron- and region-specific differences.
Conversely, a possible limitation of using such an antibody
is the simultaneous detection of non-CpG methylation,
which might serve a distinct role (Lister et al., 2009). Nev-
ertheless, while non-CpG methylation is abundant in stem
cells, its presence in postmitotic cells is very low (Lister et
l., 2009; Ramsahoye et al., 2000). Thus, considering the
elatively low proportion of dividing cells compared with
ifferentiated neurons in the hippocampus, it is unlikely that
on-CpG methylation contributes significantly to the pres-
nt results.
.6. Future directions
While the present study focused on relative measures of
lobal 5-mC IR within cells, it would be very attractive to
xtend these with analyses of methylation profiles of genes
sing whole-genome interrogation or targeted hypothesis-
ased approaches. Unfortunately, the current experimental
esign did not allow the isolation of mRNA, which pre-
ented us from examining whether the changes in 5-mC IR
(
n
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though numerous studies have already reported the effects
of aging and CR on gene expression (Lee et al., 2000; Park
and Prolla, 2005; Prolla, 2002; Prolla and Mattson, 2001;
Verbitsky et al., 2004; Weindruch et al., 2002), it would be
highly interesting to study both epigenetic phenomena as
well as their functional impact on gene expression in the
same sample. Moreover, the role of other epigenetic mod-
ifications of the DNA (e.g., DNA hydroxymethylation)
(Kriaucionis and Heintz, 2009; Tahiliani et al., 2009), and
chromatin (e.g., histone modifications) awaits further clari-
fication. The current analysis focused on levels of 5-mC per
se and did not assess age-related changes in DNA hy-
droxymethylation. Interestingly, recent studies have sug-
gested that 5-hydroxymethylcytosine (5-hmC) is an exclu-
sive product of 5-mC (Williams et al., 2011), and is
associated with chromatin opening and transcriptional acti-
vation (Jin et al., 2011; Valinluck et al., 2004; Williams et
al., 2011). Moreover, it has been shown that DNA hy-
droxymethylation serves as an intermediate step in the pro-
cess of active DNA demethylation in the brain (Guo et al.,
2011). As for DNA methylation, changes in DNA hy-
droxymethylation may play a pivotal role in the aging pro-
cess. Another interesting candidate for further investiga-
tions is repetitive element methylation. Recent studies have
suggested altered repetitive element methylation in periph-
eral lymphocytes in association with advanced age and AD,
namely a decrease in Alu methylation with age and an
increase in long interspersed element-1 (LINE-1) methyl-
ation in AD (Bollati et al., 2009, 2011).
Altogether, these first observational epigenetic studies on
the aging brain may serve as an important basis for future
experimental animal research investigating the effects of
interventions that alter DNA methylation on age-related
molecular and cellular processes in the brain and on age-
related functional decline. Such studies will be necessary to
allow further interpretation on the causal relationships be-
tween the observed age-related changes in 5-mC and age-
related functional decline.
In conclusion, the current findings reveal changes of
DNA methylation in the hippocampus with aging, in a
region-specific manner, and suggest that CR has a beneficial
effect on the life span through impacting on DNA methyl-
ation.
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